These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 24552586)
1. Quetiapine and aripiprazole signal differently to ERK, p90RSK and c-Fos in mouse frontal cortex and striatum: role of the EGF receptor. Pereira A; Zhang B; Malcolm P; Sugiharto-Winarno A; Sundram S BMC Neurosci; 2014 Feb; 15():30. PubMed ID: 24552586 [TBL] [Abstract][Full Text] [Related]
2. Clozapine regulation of p90RSK and c-Fos signaling via the ErbB1-ERK pathway is distinct from olanzapine and haloperidol in mouse cortex and striatum. Pereira A; Zhang B; Malcolm P; Sundram S Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():353-63. PubMed ID: 23142770 [TBL] [Abstract][Full Text] [Related]
3. Clozapine induction of ERK1/2 cell signalling via the EGF receptor in mouse prefrontal cortex and striatum is distinct from other antipsychotic drugs. Pereira A; Sugiharto-Winarno A; Zhang B; Malcolm P; Fink G; Sundram S Int J Neuropsychopharmacol; 2012 Sep; 15(8):1149-60. PubMed ID: 21943960 [TBL] [Abstract][Full Text] [Related]
4. Clozapine-induced ERK1 and ERK2 signaling in prefrontal cortex is mediated by the EGF receptor. Pereira A; Fink G; Sundram S J Mol Neurosci; 2009 Sep; 39(1-2):185-98. PubMed ID: 19277491 [TBL] [Abstract][Full Text] [Related]
5. Partial agonists in schizophrenia--why some work and others do not: insights from preclinical animal models. Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S Int J Neuropsychopharmacol; 2011 Oct; 14(9):1165-78. PubMed ID: 21087552 [TBL] [Abstract][Full Text] [Related]
6. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics. Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652 [TBL] [Abstract][Full Text] [Related]
7. Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats. Der-Ghazarian T; Charntikov S; Varela FA; Crawford CA; McDougall SA J Neural Transm (Vienna); 2010 May; 117(5):573-83. PubMed ID: 20372943 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological blockade of dopamine D2 receptors by aripiprazole is not associated with striatal sensitization. Koener B; Goursaud S; Van De Stadt M; Calas AG; Jeanjean AP; Maloteaux JM; Hermans E Naunyn Schmiedebergs Arch Pharmacol; 2011 Jan; 383(1):65-77. PubMed ID: 21061116 [TBL] [Abstract][Full Text] [Related]
9. c-Fos and FosB/ΔFosB colocalizations in selected forebrain structures after olanzapine, amisulpride, aripiprazole, and quetiapine single administration in rats preconditioned by two different mild stressors sequences. Kiss A; Osacka J Endocr Regul; 2020 Jan; 54(1):43-52. PubMed ID: 32597143 [TBL] [Abstract][Full Text] [Related]
10. Slow dissociation of partial agonists from the D₂ receptor is linked to reduced prolactin release. Carboni L; Negri M; Michielin F; Bertani S; Fratte SD; Oliosi B; Cavanni P Int J Neuropsychopharmacol; 2012 Jun; 15(5):645-56. PubMed ID: 21733233 [TBL] [Abstract][Full Text] [Related]
11. In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain. Bortolozzi A; Díaz-Mataix L; Toth M; Celada P; Artigas F Psychopharmacology (Berl); 2007 Apr; 191(3):745-58. PubMed ID: 17265076 [TBL] [Abstract][Full Text] [Related]
12. The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory : A dual [(11)C]raclopride and [(18) F]FDG imaging study with aripiprazole. Kim E; Howes OD; Turkheimer FE; Kim BH; Jeong JM; Kim JW; Lee JS; Jang IJ; Shin SG; Kapur S; Kwon JS Psychopharmacology (Berl); 2013 May; 227(2):221-9. PubMed ID: 23271192 [TBL] [Abstract][Full Text] [Related]
13. A model of anticholinergic activity of atypical antipsychotic medications. Chew ML; Mulsant BH; Pollock BG; Lehman ME; Greenspan A; Kirshner MA; Bies RR; Kapur S; Gharabawi G Schizophr Res; 2006 Dec; 88(1-3):63-72. PubMed ID: 16928430 [TBL] [Abstract][Full Text] [Related]
14. Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride. Kegeles LS; Slifstein M; Frankle WG; Xu X; Hackett E; Bae SA; Gonzales R; Kim JH; Alvarez B; Gil R; Laruelle M; Abi-Dargham A Neuropsychopharmacology; 2008 Dec; 33(13):3111-25. PubMed ID: 18418366 [TBL] [Abstract][Full Text] [Related]
15. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride. Yokoi F; Gründer G; Biziere K; Stephane M; Dogan AS; Dannals RF; Ravert H; Suri A; Bramer S; Wong DF Neuropsychopharmacology; 2002 Aug; 27(2):248-59. PubMed ID: 12093598 [TBL] [Abstract][Full Text] [Related]
16. Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models. Natesan S; Reckless GE; Nobrega JN; Fletcher PJ; Kapur S Neuropsychopharmacology; 2006 Sep; 31(9):1854-63. PubMed ID: 16319908 [TBL] [Abstract][Full Text] [Related]